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ABSTRACT 
Objective: The aim of this study was to acquire supporting data for the rational use of antibiotics in plastic reconstructive surgery in the Ear-Nose-
Throat/Head and Neck Surgery Department at Cipto Mangunkusumo Hospital–Faculty of Medicine Indonesia University.  
Methods: This pilot study, with a negative trial design, included 12 subjects who were randomly divided into two groups: preoperative prophylactic 
antibiotic-only group and a combination of prophylactic and postoperative antibiotic group (controls).  
Results: The results showed that only 1 of the 12 subjects (in the prophylactic antibiotic-only group) developed an SSI. None of the controls 
(combined-use group) had an SSI. The difference between the two groups was not significant.  
Conclusion: The use of postoperative antibiotic appears not to be necessary in plastic reconstructive surgery patients to prevent SSIs. Further 
study, however, is required to support the findings of this study. 
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INTRODUCTION 
Surgical-site infections comprise one of the most common causes of 
morbidity and mortality following head and neck surgery. Infection 
has a negative effect on the prognosis, prolongs hospitalization, and 
contributes to a less acceptable cosmetic outcome. The cost of care 
for patients with infection triples compared with that for patients 
without infection. The incidence of infection is reported at 8–45% 
with the proper use of prophylactic antibiotics. [1–4]. 
Surgical wound infection is characterized by signs of acute inflammation, 
such as edema, hyperemia, purulent secretion production, and pain, and 
may be accompanied by fever. Infection of surgical wounds causes 
disruption of the wound-healing process, which is divided into three 
phases: inflammation, proliferation, and remodeling [5]. 
The most common pathogen of SSIs following head and surgery is 
Staphylococcus aureus. Data from the Ear Nose and Throat (ENT) 
Department at Cipto Mangunkusumo General Hospital revealed that 
Klebsiella pneumoniae (16.67%), Klebsiella oxytoca (12.5%), and 
Staphylococcus epidermidis (12.5%) were their most common 
pathogens. SSIs after head and neck surgery are caused by surgical 
wound contamination with endogenous flora from the skin or 
aerodigestive tract. One of the strategies used to reduce the risk of 
SSIs is decolonization using antiseptic soap [5-8]. 
The rational use of antibiotics is important for preventing 
microorganism resistance, decreasing hospital-related infections, and 
maintaining cost-effectiveness. If infection is diagnosed, it is common 
to prescribe an empirical antibiotic. The duration of surgery also 
determines the use of prophylactic antibiotics. Reconstructive plastic 
surgery in the ENT field is often lengthy. Ear reconstruction, for 
example, requires a prolonged operation time because of the 
complexity of the actions taken, starting with rib removal to obtain 
material with which to forming the framework to then positioning that 
framework. Prophylactic antibiotics can be given during surgery that 
lasts>4 h by repeating the dose intraoperatively according to the 
antibiotic’s half-life. Existing research suggests that repeated doses of 
intraoperative cefazolin during surgery lasting>4 h reduced the 
incidence of SSIs from 16.0% to 7.7% [1]. 
The World Health Organization has established antimicrobial 
resistance as a global health problem. Increased human mobility and 
world trade result in the possibility of resistance spreading 
worldwide, with uncontrolled use of antibiotics an important factor 
in accelerating the rate of antimicrobial resistance [5, 9]. 
This study generally aimed to obtain data to support the scientific 
rational use of antibiotics in the management of ear and nose 
reconstructive surgery in the Department of Otorhinolaryngology–
Head and Neck Surgery (ORL-HNS) at the Cipto Mangunkusumo 
Hospital–Faculty of Medicine Indonesia University (CMH–FMUI). 
This study specifically aimed to determine the incidence of 
postoperative infections following ear and nose reconstructive 
surgery in our department with either prophylactic antibiotic use 
only or a combination of prophylactic and postoperative antibiotics. 
We recorded the incidence of edema, hyperemia, pain, and purulent 
secretion production in SSIs after ear and nose reconstructive 
surgery to determine the relation between administering a 
prophylactic antibiotic alone versus combined prophylactic and 
postoperative antibiotic on the incidence of SSIs following ear and 
nose reconstructive plastic surgery.  
MATERIALS AND METHODS 
This research is a preliminary study in which we planned to enroll 
10 consecutive patients per group over a 6-month period. Patients 
included in this study were male and female, 6–60 y old, who 
underwent an ear or nose reconstructive procedure in the 
Otorhinolaryngology Head and Neck Surgery Department Cipto 
Mangunkusumo Hospital. Patients who had a history of antibiotics 
use 7 d prior to surgery or a chronic infection were excluded from 
the study. The remaining patients were grouped into treatment and 
control groups based on a randomization method that comprised 
giving patients envelopes containing numbers. Those with odd 
numbers were assigned to the treatment group and those with even 
numbers to the control group. These patients then underwent the 
following procedures. 
1. Surgical preparation that included bathing with an antiseptic 
solution and shaving. 
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2. Nose and/or ear reconstruction surgery. 
3. Treatment group were given prophylactic antibiotics alone, 
whereas the control group were given both prophylactic and 
postoperative antibiotics. 
4. Wound dressings were changed by the researcher, who assessed 
the wound for signs of infection. Wound care was performed with 
sterile devices and infection prevention methods (e. g., hand washing) 
according to CMH standards. Infection prevention methods were used 
both in the hospital and at home. Evaluation was carried out on 
postoperative days (PODs) 10, 20, and 30. Variables assessed at each 
evaluation point indicating a possible SSI were edema, hyperemia, 
purulent discharge, and postoperative pain. Procalcitonin (a 
biomarker for postoperative infection) was assayed on POD 7.  
5. Patients discharged from the hospital were given an educational 
sheet regarding at-home wound care.  
6. Patients with postoperative infection in either group underwent 
culture and resistance testing of microorganisms in the surgical 
wound and were given empirical or definitive antibiotic therapy 
depending on the resistance evident in the culture examinations. 
These measures were important for avoiding any ethical issues 
regarding the management of patients with an SSI.  
7. Test results were documented and then analyzed. 
Univariate analysis was performed on the subjects’ characteristics as 
middle values and their deviations or frequency distribution. A 
bivariate analysis was performed to prove the hypothesis by the 2
RESULTS 
 
test and risk ratio (RR), with P<0.05 indicating significance. The 
collected data were also processed to determine the control event 
rate (CER) and the experimental event rate (EER). 
This preliminary research was conducted from February to July 
2016. The study initially involved 13 subjects according to the 
established research criteria, but one subject dropped out during the 
data collection process. 
The subjects with clean or contaminated wounds underwent 
surgery, with the contaminated clean operations comprising the 
largest group (n=7). The duration of the surgery in this study had a 
4-h cutoff, with more subjects (n=8) undergoing surgery lasting<4 h. 
All 12 study subjects received prophylactic antibiotics a maximum of 
30 min before incision, with 4 of them requiring repetition of the 
prophylactic antibiotic doses because their surgery lasted ≥4 h. The 
prophylactic antibiotic was intravenous cefazolin at a dose of 2 g in 
adult patients and a corresponding dose according to body weight in 
pediatric patients. There were a median of 6 (range 5–10) medical 
personnel in the operating room during the surgery (table 1). 
 
Table 1: Characteristics of the subjects 
Characteristic No. of subjects  
Type of surgery  
Stage 1 auiriculoplasty with rib cartilage graft  2 
Stage 2 auriculoplasty with split-thickness skin graft  1 
Otoplasty 1 
Fistulectomy  1 
Septoplasty  2 
Septoplasty with osteotomy 3 
Augmentation rhinoplasty with cartilage graft  2 
Ear reconstruction surgery  
With drain 3 
Without drain  2 
Nose reconstruction surgery   
With nasal packing 7 




Fig. 1: Postoperative clinical characteristics in the experimental 
and control groups 
Reconstructive surgery varies for both ear and nasal reconstruction. 
Ear reconstruction ranges from simple actions such as fistulectomy 
to complex actions such as auriculoplasty with cartilage insertion. 
All ear reconstruction procedures are performed on skin. Nasal 
reconstruction is quite different, where there is action concerning 
the location of the mucosal incision (as for septoplasty) and that in 
the skin and mucosa (as for augmentation rhinoplasty) with the 
installation of cartilage grafts. 
The incidences of edema, hyperemia, pain, surgical wounds, and 
purulent discharge in the experimental and control groups from POD 
2 to POD 30 are shown in fig. 1. These clinical signs were found 
mostly on POD 2, decreasing gradually at the assessments on PODs 
10, 20, and 30. Diminishing edema was seen more often in the 
control group than in the experimental group. 
Evaluation revealed that only one subject (in the experimental 
group) still had tissue edema, tissue hyperemia, and purulent 
secretions by POD 20. Blood procalcitonin and surgical wound 
swabs were then examined for that patient. The procalcitonin level 
proved to be elevated (0.06 mg/dL), and examination of the wound 
swab revealed the presence of Staphylococcus aureus. Resistance 
testing showed that the bacteria were sensitive to levofloxacin. 
Hence, that subject was given levofloxacin 1 × 500 mg orally for 5 d. 
Evaluation on POD 30 showed no signs of edema, hemorrhagic fever, 
or purulent discharge.  
Postoperative clinical features of an SSI include fever, pain at the 
surgical site, tissue hyperemia, and purulent discharge. At the 
evaluation on POD 2, most of the study subjects showed signs of 
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inflammation in the form of tissue edema (n=12), tissue hyperemia 
(n=10), and surgical wound pain (n=10). The number of subjects 
with inflammatory manifestations diminished on PODs 10 and 20, 
and on POD 30 there was no edema, hyperemia, surgical wound 
pain, or purulent discharge in any of the subjects. The relation 
between the clinical parameters (tissue edema, tissue hyperemia, 
purulent discharge, surgical wound pain) and the possibility of an 
SSI is shown in table 2. 
 
Table 2: Clinical features and surgical-site infections 
Variable Surgical-site infection P 
Yes (n=1) No (n=11) 
Pain    
 POD 2 (n=10) 1 9 1.000 
 POD 10 (n=4) 0 4 1.000 
Edema     
 POD 10 (n=3) 0 3 1.000 
  POD 20 (n=1) 1 0 0.083 
Hyperemia    
 POD 2 (n=10) 0 10 0.167 
 POD 20 (n=1) 1 0 0.083 
Purulent discharge    
 POD 20 (n=1) 1 0 0.083 
POD, postoperative day 
 
Table 3: Relation between prophylactic antibiotics and combined prophylactic and postoperative antibiotics with surgical-site infection 
Group Surgical-site infection P 
Yes (n=1) No (n=11) 
Prophylactic antibiotic+postoperative antibiotic 0 6  
1.000 Prophylactic antibiotic only 1 5 
 
The relation between prophylactic antibiotic administration versus a 
combination of prophylactic antibiotics and postoperative antibiotics 
with the incidence of SSIs is shown in table 3. One subject in the 
prophylactic antibiotic (experimental) group experienced an SSI, 
whereas there were no SSIs in the combined prophylactic antibiotic 
and postoperative antibiotic group. There was no significant difference 
between the experimental and control groups (p = 1.000). The CER, 
EER, absolute risk reduction (ARR) and number needed to treat (NNT) 
were calculated from the data in table 3. In this study, CER 0, EER 
0.167, ARR −0.167, and NNT −6 were obtained. 
DISCUSSION 
The types of surgical wounds in these research subjects were clean 
and clean-contaminated. This type of surgery can also affect the 
incidence of SSIs as the risk increases with the degree of 
contamination of the incision. In this study, subjects with SSIs were 
included in the type of contaminated-clean surgery. In addition to 
the type of wound, the location of the incision affectd the risk of an 
SSI. There are differences in wound healing of skin and mucosa. 
Mucosal wounds heal faster and with less scarring than skin 
lesions—perhaps because of the greater hypoxic condition in the 
skin than in the mucosa, although oxygen is important for optimal 
wound healing. This hypoxic state is characterized by higher HIF-1α 
expression in skin lesions than mucosal lesions [5, 10]. 
A prolonged operating duration can increase the risk of an SSI. Based 
on Nwankwo et al., the operating duration of>2 h can increase the 
risk of surgical wound infection fourfold. This study used a 4-h limit 
to assess the duration of surgery (based on other studies). In this 
study, the incidence of surgical wound infection occurred in 1 
subject with an operating duration of<4 h [5, 11]. 
All study subjects received a prophylactic antibiotic (i.e., intravenous 
cefazolin). The choice of cefazolin as a prophylactic antibiotic is 
based on the prevailing resistance pattern at CMH. Cefazolin is a 
first-generation, broad-spectrum cephalosporin antibiotic, effective 
against Gram-positive and Gram-negative bacteria. The dose of 
cefazolin for prophylaxis in adults is 2 g intravenously. In children, 
the dose is measured as 30 mg/kg body weight per dose [12, 13]. 
All subjects in this study received prophylactic antibiotics within 30 
min before the incision. Based on the literature, the optimal time to 
provide a prophylactic antibiotic is 0–30 min before the incision. The 
risk of infection is increased if the prophylactic antibiotic is 
administered>30 min before or after the incision. Prophylactic 
antibiotic doses can be repeated if the duration of surgery is>4 h. In 
this study, four subjects underwent with an operating that lasted ≥4 
h. All subjects received repeated prophylactic antibiotic doses at 4-h 
intervals [5, 13, 14]. 
The number of medical personnel in the operating room can also 
affect the incidence of SSIs. Nwankwo et al. found a significant 
difference in the incidence of SSIs when there were more than six 
medical personnel present. In this study, an SSI occurred in one 
subject whose intraoperative staff included six medical personnel. 
The highest number of intraoperative medical personnel was 10 in 
this study, but with no other subject developing an SSI [11, 14]. 
Drains are often placed during ear reconstructive surgery. Three of 
our research subjects required drainage. The drain could increase 
the risk of SSIs because it is an entry route for bacteria. Therefore, it 
must be removed as quickly as possible. In two subjects who 
underwent stage 1 auriculoplasty, the drain was removed on POD 5, 
whereas in those who underwent fistulectomy they were removed 
on POD 2. This difference is due to the function of the flow following 
these two operations. For auriculoplasty, in addition to drainage, 
saliva functions as a negative pressure provider to achieve better 
aesthetic results [5, 15, 16]. 
Among our 12 subjects, 7 required anterior nasal packing, which 
could be a source of bacterial infection. In addition, the installation 
of nasal packing poses a risk of toxic shock syndrome due to 
infection with Staphylococcus aureus or Streptococcus pyogenes. 
Routine antibiotics are used after posterior packing, such as co-
amoxiclav 625 mg, up to three doses per day starting from the time 
of drainage installation until up to 5 d after its removal. For anterior 
packing, a systemic antibiotic is not required if the packing is 
removed within 48 h. If the packing is maintained for>48 h, co-
amoxiclav 625 mg is given three times per day for up to 5 d after the 
packing is removed. In this study, seven subjects with postoperative 
anterior packing underwent its removal 48 h later, so there was no 
need for a systemic antibiotic. The principle of preventing infection 
due to nasal packing is applicable not only to postoperative patients 
but also those with epistaxis [17]. 
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At the POD 20 evaluation, only 1 of the 12 subjects (from the 
experimental group) experienced edema, hyperemia, and purulent 
discharge as well as an elevated procalcitonin level (0.06 mg dL) 
when compared with that on POD 7 (0.02 mg/dL). The presence of 
those clinical features accompanied by an increased procalcitonin 
level led to the diagnosis of an SSI. The subjects diagnosed with nasal 
os fractures underwent septorhinoplasty with osteotomy. On POD 
20, they had septal edema and hyperemia that had not been present 
at the previous evaluation. In addition, there were purulent 
secretions originating from the media meatus so it was suspected 
that there was an SSI that manifested as acute sinusitis accompanied 
by septal cellulitis. Septorhinoplasty is considered clean-
contaminated surgery, and bacterial flora and normal infections can 
occur in the nasal mucosa. The most common cause of an SSI 
following septorhinoplasty is Staphylococcus aureus. This study 
obtained similar results, with the microorganisms cultured from 
septal swabs and media meatus were identified as S. aureus. 
Andrews reported the most infectious bacterium, S. aureus, in seven 
subjects. Other pathogenic bacteria include Klebsiella sp. and Proteus 
sp, Salmonella, and Morganella morganii [5, 18]. 
The affected subject in this preliminary trial was given definitive 
antibiotic therapy based on the results of resistance cultures. 
Staphylococcus aureus, the pathogenic bacterium in our subject, was 
sensitive to amoxicillin-clavulanate. However, because many 
individuals are allergic to amoxicillin, other antibiotics have been 
adopted, including levofloxacin, to which this S. aureus was sensitive. 
This subject was given levofloxacin for 5 d, at which time the edema, 
hyperemia, and purulent secretions had disappeared. Levofloxacin, a 
respiratory fluoroquinolone, is recommended as an alternative in 
patients with acute sinusitis with penicillin allergy. The duration of 
antibiotic administration is determined by the clinical response. 
According to a systematic literature review of antibiotic use in 
bacterial acute sinusitis, data indicated that administration of 
antibiotics for 5 d had the same effectiveness as when given for 10 d. 
The duration of long-term antibiotic administration is related to the 
appearance of drug-related side effects. The incidence of these side 
effects was lower in patients with a 5-day regimen than in those on a 
10-day regimen, with an odds ratio of 0.79 [19, 20]. 
SSIs are caused by various factors. In our subject, the infection 
manifested as edema and hyperemia of the septal mucosa 
accompanied by a purulent discharge from the media meatus. These 
clinical features indicated the presence of acute sinusitis 
accompanied by septal cellulitis. Based on the literature, 
complications of an infection after septorhinoplasty can be acute or 
chronic sinusitis, caused by disruption of the function of the 
osteomeatal complex due to actions taken during septorhinoplasty 
(e. g., osteotomy). Andrews et al. reported two subjects who 
experienced septal cellulitis complications that were included in the 
criteria for “major” infection. The study classified the degree of 
infection of the surgical wound as a minor degree of vestibulitis or a 
major degree of septal or nasal cellulitis and secondary bleeding. 
The infection that occurred in our research subject might have been 
influenced by occupational factors. The subject with the SSI was a 
nurse at CMH. Based on the epidemiological triad (host–agent–
environment), infections could be due to the interaction of the three 
factors. This subject, as a nurse, had repeated contact with sources of 
infection [18, 21, 22]. 
In the present study, the number of subjects with inflammatory 
features in the form of edema, hyperemia, and surgical wound pain 
continued to decreased on PODs 10 and 20 until, finally, on POD 30, 
no clinical manifestations were found in any of the subjects. This is 
consistent with the wound-healing phase, where during the 
proliferative and remodeling phases, the role of inflammatory 
cytokines has begun to diminish and is being replaced by a fibrin 
matrix and granulation tissue. The remodeling phase, however, 
continues for about a year [23, 24].  
In this study, the postoperative clinical features were associated with the 
incidence of SSIs. In the assessment of surgical wound pain on PODs 2 
and 10, there was no significant association with an SSI (p = 1.000). 
Evaluation of edema on PODs 10 and 20 also found no significant 
relation (p = 1.000 and p = 0.083, respectively). Likewise with hyperemic 
assessment on PODs 2 and 20 (p = 0.167 and p = 0.083, respectively) and 
purulent discharge on POD 20 (p = 0.083). However, the presence of 
edema, hyperemia, and purulent discharge on POD 20 could be an 
indication of SSI. This is in accordance with the process of wound 
healing, wherein the signs of inflammation have begun to decrease at the 
end of the inflammatory phase (POD 7). The presence of inflammatory 
signs on POD 20 indicates the possibility of an infection that interferes 
with the healing process of the wound [5, 23, 24]. 
The incidence of SSIs in the current study included only one subject 
in the experimental group. None of the subjects in the control group 
had an SSI. The proportional difference in these two groups was not 
statistically significant (p = 1.000). This finding is consistent with a 
study, conducted by Andrews et al., which found that there were no 
significant differences between administering prophylactic and 
postoperative antibiotics for septorhinoplasty surgery. Andrews et 
al. reported the proportion of SSIs in the prophylactic antibiotic 
group at 7% and in the postoperative antibiotic group at 11%, with 
the total proportion of SSIs for all subjects at 9%. The present study, 
though, had differences in patient selection. Our study involved 
those who underwent clean and clean-contaminated surgery, 
whereas that of Andrews et al. involved only subjects who 
underwent clean-contaminated surgery [18]. 
Pathogenic bacteria that caused the infection in this study was 
Staphylococcus aureus, which has an incubation period of 2–10 d. In 
subjects with SSIs, signs of infection are usually apparent by POD 20. 
Based on these findings, it can be concluded that bacterial infections 
manifest on PODs 10–18. The postoperative antibiotic in this study 
was administered on POD 7. Therefore, the risk of infection in these 
subjects was no different between those given a prophylactic 
antibiotic only and those given a prophylactic antibiotic and a 
postoperative antibiotic [25] 
Statistical calculations showed EER values of 0.167, CER 0, ARR 
−0.167, and NNT −6. The ARR value was<0, so it can be concluded that 
the absolute risk increased in the experimental group. In this study, 
the absolute risk of developing an SSI after a prophylactic antibiotic 
alone increased by 16.7% when compared with those given the 
prophylactic antibiotic-postoperative antibiotic combination. The NNT 
was also<0 so it was concluded that it was the number needed to harm 
(not to treat). Thus, in this study, the number to harm was six, so it can 
be concluded that when giving only six patients a prophylactic 
antibiotic, one patient would develop an SSI. 
This research comprises a preliminary study with a design that aims 
to prove the differences in proportions between two groups. It did 
prove that the proportion of the two groups was not significantly 
different, but it needs to be continued in a negative clinical trial that 
requires a larger sample size. The present study found one SSI in the 
prophylactic antibiotic-only group. However, this study was not able 
to eliminate the confounding factors that exist primarily from 
environmental factors as the cause of SSIs.  
CONCLUSION 
The rational use of perioperative antibiotics is important for 
decreasing the risk of SSIs. Although there was no significant 
relation found in this study, further evaluation is required to prove 
the effectiveness of the rational use of antibiotics for avoiding SSIs. 
Such infections can be diagnosed via a thorough postoperative 
examination looking for typical signs such as edema, hyperemia, and 
purulent discharge. 
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